Highlights from 2024 NEI Synapse: We Didn’t Write the Rx: A Guide to the Pros and Cons of Complementary and Alternative Medicine
April 21, 2024
Complementary health approaches are commonly used by patients seeki...
Read More
Metabolic Markers Tied to Increased Risk of Mental Disorders
April 6, 2024
A recent study examined whether the biomarkers of carbohydrate, lip...
Read More
CDC Issues New Guidance on Identifying, Responding to Suicide Clusters
March 19, 2024
Responding to suicide clusters requires a comprehensive and proacti...
Read More
Highlights from 2023 NEI Congress: Scientific Poster Session Winners
November 10, 2023
The 2023 NEI Congress Scientific Poster Session was held on Friday,...
Read More
Suicide Risk Among Patients Hospitalized With Psychiatric Illness
October 26, 2023
Fifteen to thirty percent of patients with a history of concussion ...
Read More
Meet DEA Training Requirements
October 16, 2023
Activities available as part of NEI Membership can fulfill the new,...
Read More
Updates to DSM-5-TR Criteria and Text
September 13, 2023
The American Psychiatric Association (APA) released DSM-5-TR™ Updat...
Read More
CDC Estimates Suicides in U.S. Reached All-Time High in 2022
September 1, 2023
Provisional data released by the Center for Disease Control and Pre...
Read More
World Schizophrenia Day: Education and Tool for Providers
May 24, 2023
The high rates of treatment resistance, relapse rates, and incidenc...
Read More
2023 NEI Synapse: Biggest Mistakes in Psychopharm
April 2, 2023
On Saturday, April 1, we rounded out a fantastic 2023 NEI Synapse m...
Read More
FDA Approves First Over-the-Counter Naloxone Nasal Spray
March 29, 2023
The U.S. Food and Drug Administration approved naloxone hydrochlori...
Read More
The Future of Psychopharmacology
February 9, 2023
It is an incredible time in terms of the development of new psychop...
Read More